Subscribe to receive future Ambry updates!
Ambry Genetics Will Vigorously Defend Against BRCA1 and BRCA2 Gene Patent Infringement Suit
Ambry Genetics Launches BRCA 1 & 2: Single Genes and NGS Panel Offerings
CEOCFO Magazine Interview with Charles Dunlop
Ambry Genetics Leading the Way With Clinical Next-Generation Sequencing
Somatic Mutation Analysis
Milestone: 10,000 Diagnostic & 100,000 Genomic NGS Samples
Diagnosing Rare Disorders Using Next Generation Sequencing
Ambry Genetics Chairman and CEO Charles Dunlop Honored with RARE Champion Award at Global Genes Project’s Champions of Hope Gala
The Clinical Exome: The Brass Ring of Molecular Testing?
Ambry Genetics Catches the Clinical Sequencing Wave
Start your search...